Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Biotron Limited
No Price
Closing Price OTC 28.04.2026:
0,03 USD
28.04.2026 20:00
Current Prices from Biotron Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
BITRF
USD
28.04.2026 20:00
0,03 USD
0,00 USD
Company Profile for Biotron Limited Share
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
